18.80

0.92% 0.38

Mediwound Ltd (MDWD)

Overview News Price History Option Chain Discussions Forecast Stock Split

Mediwound Ltd stock is traded at $18.80, with a volume of 22,456. It is up +0.92% in the last 24 hours and up +12.73% over the past month. MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Previous Close:

$18.42

Open:

$18.34

24h Volume:

22,456

Relative Volume:

0.42

Market Cap:

$198.75M

Revenue:

$19.85M

Net Income/Loss:

$-12.75M

P/E Ratio:

-13.62

EPS:

-1.38

Net Cash Flow:

$-21.94M

1W Performance:

-3.58%

1M Performance:

+12.73%

6M Performance:

-3.13%

1Y Performance:

+37.81%

1-Day Range:

$18.16

$18.75

1-Week Range:

$17.47

$19.38

52-Week Range:

$11.04

$24.00

Mediwound Ltd Stock (MDWD) Company Profile

Name

Mediwound Ltd

Sector

Healthcare (1177)

Industry

Biotechnology (685)

Phone

Address

Employee

Twitter

Next Earnings Date

2024-11-19

Latest SEC Filings

MDWD's Discussions on Twitter

Compare MDWD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDWD Mediwound Ltd	18.75	198.75M	19.85M	-12.75M	-21.94M	-1.38
VRTX Vertex Pharmaceuticals Inc	430.86	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	693.64	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.36	38.87B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	265.71	34.11B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	115.09	27.84B	3.30B	-501.07M	1.03B	-2.1146

Mediwound Ltd Stock (MDWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-16-24	Reiterated	Maxim Group	Buy
Dec-22-22	Initiated	Maxim Group	Buy
Jul-18-22	Resumed	Oppenheimer	Outperform
Sep-23-20	Initiated	BTIG Research	Buy
Nov-28-16	Initiated	Aegis Capital	Buy
Aug-17-16	Initiated	Wells Fargo	Outperform
Apr-16-14	Initiated	Oppenheimer	Outperform

View All

Mediwound Ltd Stock (MDWD) Latest News

Jan 21, 2025

Burns Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma, Avita Medical, Vericel Corp - The Globe and Mail

Jan 21, 2025

Jan 16, 2025

Trading (MDWD) With Integrated Risk Controls - Stock Traders Daily

Jan 16, 2025

Jan 12, 2025

HC Wainwright Reaffirms “Buy” Rating for MediWound (NASDAQ:MDWD) - Defense World

Jan 12, 2025

Jan 10, 2025

MediWound (NASDAQ:MDWD) Receives "Buy" Rating from HC Wainwright - MarketBeat

Jan 10, 2025

Jan 09, 2025

Mediwound Advances in Enzymatic Therapeutics with Strategic Expansions - Yahoo Finance

Jan 09, 2025

MediWound Ltd.'s (NASDAQ:MDWD) P/S Still Appears To Be Reasonable - Simply Wall St

Jan 09, 2025

Geode Capital Management LLC Sells 2,365 Shares of MediWound Ltd. (NASDAQ:MDWD) - Defense World

Jan 09, 2025

Jan 07, 2025

Barclays PLC Raises Stake in MediWound Ltd. (NASDAQ:MDWD) - Defense World

Jan 07, 2025

Jan 05, 2025

When (MDWD) Moves Investors should Listen - Stock Traders Daily

Jan 05, 2025

Jan 03, 2025

State Street Corp Raises Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World

Jan 03, 2025

State Street Corp Purchases 45,529 Shares of MediWound Ltd. (NASDAQ:MDWD) - MarketBeat

Jan 03, 2025

Dec 28, 2024

MediWound (NASDAQ:MDWD) Shares Pass Below 50 Day Moving AverageTime to Sell? - MarketBeat

Dec 28, 2024

Dec 26, 2024

Learn to Evaluate (MDWD) using the Charts - Stock Traders Daily

Dec 26, 2024

Dec 24, 2024

We're Keeping An Eye On MediWound's (NASDAQ:MDWD) Cash Burn Rate - Yahoo Finance

Dec 24, 2024

Dec 20, 2024

Charles Schwab Investment Management Inc. Decreases Position in MediWound Ltd. (NASDAQ:MDWD) - Defense World

Dec 20, 2024

Dec 19, 2024

MediWound Approves 2024 Share Incentive Plan to Boost Employee Engagement - TipRanks

Dec 19, 2024

Dec 17, 2024

MediWound to Host Virtual Key Opinion Leader Event to - GlobeNewswire

Dec 17, 2024

MediWound Announces Expert Panel Event: Phase III Trial Plans for Revolutionary Wound Treatment EscharEx - StockTitan

Dec 17, 2024

MediWound Executives Acquire 18,462 Shares, Signaling Confidence in Company’s Future - Yahoo Finance

Dec 17, 2024

Dec 15, 2024

(MDWD) Long Term Investment Analysis - Stock Traders Daily

Dec 15, 2024

Dec 11, 2024

MetLife Investment Management LLC Acquires New Shares in MediWound Ltd. (NASDAQ:MDWD) - Defense World

Dec 11, 2024

Dec 02, 2024

MDWD (MediWound) Price-to-Operating-Cash-Flow : (As of Dec. 02, 2024) - GuruFocus.com

Dec 02, 2024

FY2024 EPS Estimates for MediWound Lowered by HC Wainwright - MarketBeat

Dec 02, 2024

Brokers Offer Predictions for MediWound FY2024 Earnings - Defense World

Dec 02, 2024

Dec 01, 2024

MediWound (FRA:M8W) Price-to-Free-Cash-Flow : N/A (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024

Nov 29, 2024

Earnings Update: MediWound Ltd. (NASDAQ:MDWD) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St

Nov 29, 2024

Nov 27, 2024

HC Wainwright Cuts MediWound (NASDAQ:MDWD) Price Target to $25.00 - MarketBeat

Nov 27, 2024

MediWound Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Nov 27, 2024